Supposedly we are waiting for clinical trial updates for VAXINIA and OASIS in Q2 as well and Azer-Cel in Q4 so they are similar updates to IMU and IMU's pps is also cheap right now. IND and ethics approval and commencing Ph1 clinical trial are expected announcements for biotech start-up stock so wouldn't expect these announcement to move the pps much.
Supposedly we are waiting for clinical trial updates for VAXINIA...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
-0.001(7.69%) |
Mkt cap ! $89.60M | |||
| Open | High | Low | Value | Volume |
| 1.4¢ | 1.4¢ | 1.2¢ | $256.4K | 19.68M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 71 | 13507871 | 1.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.3¢ | 4334243 | 26 |
View Market Depth
| Last trade - 15.07pm 19/06/2025 (20 minute delay) ? |
| IMU (ASX) Chart |